Clinical trials

ClinicalTrials.gov record NCT07463846↗

PeptideScanner retained ClinicalTrials.gov record NCT07463846 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide.↗

Source record context

What this record can answer

This page can answer what the retained ClinicalTrials.gov observation for NCT07463846 records: the status, phases, conditions and interventions shown at that observation. It does not provide or establish participant outcomes, safety, effectiveness, approval or a recommendation to use an intervention.

ClinicalTrials.gov record NCT07463846 · Open source record ↗

Continue with profile context

These profile links provide broader, bounded context while keeping this source record’s identity and version separate.

Update · November 15, 2026

ClinicalTrials.gov posted a newer version of NCT07463846, with a registry update date of 2026-11-12. This version reports that observation; the earlier retained observation remains available as version 1. 1

This version supersedes public version 1.

PeptideScanner retained ClinicalTrials.gov record NCT07463846 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1

Complete submitted registry timeline

5 ClinicalTrials.gov record-history versions

Explore all trial histories →

ClinicalTrials.gov lists these public versions with submitted dates from March 6, 2026 through August 11, 2026. Each entry links to the exact public source version and reports only the source-declared status, study type, dates, and changed-module labels.

  1. NCT07463846 · history version 1

    March 6, 2026

    Open exact source version ↗
    Registry status
    Recruiting
    Study type
    interventional
    Last submitted QC date
    March 6, 2026

    Source-declared changed modules: None listed for this version

  2. NCT07463846 · history version 2

    May 12, 2026

    Open exact source version ↗
    Registry status
    Recruiting
    Study type
    interventional
    Last submitted QC date
    May 12, 2026

    Source-declared changed modules: Contacts/Locations, Study Status

  3. NCT07463846 · history version 3

    June 10, 2026

    Open exact source version ↗
    Registry status
    Recruiting
    Study type
    interventional
    Last submitted QC date
    June 10, 2026

    Source-declared changed modules: Study Status

  4. NCT07463846 · history version 4

    July 22, 2026

    Open exact source version ↗
    Registry status
    Recruiting
    Study type
    interventional
    Last submitted QC date
    July 22, 2026

    Source-declared changed modules: Study Status

  5. NCT07463846 · history version 5

    August 11, 2026

    Open exact source version ↗
    Registry status
    Recruiting
    Study type
    interventional
    Last submitted QC date
    August 11, 2026

    Source-declared changed modules: Study Status

Sources and evidence

  1. 1

Preserved public versions

Earlier versions of this record

Every earlier public version is kept here with its original wording and sources. The current version above supersedes them.

Superseded public version 1

Version 1: ClinicalTrials.gov record NCT07463846↗

PeptideScanner retained ClinicalTrials.gov record NCT07463846 at 2026-08-13T05:54:14.856Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.↗

PeptideScanner retained ClinicalTrials.gov record NCT07463846 at 2026-08-13T05:54:14.856Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide. 1

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1

Sources for version 1

  1. 1